Classify hypersensitivity reactions. Describe each type with its mechanism and examples.
Definition and Classification
Hypersensitivity is an exaggerated or inappropriate immune response to an antigen, resulting in tissue damage. Gell and Coombs described four types.
| Type | Name | Mediator | Time to onset |
|---|---|---|---|
| I | Immediate (anaphylactic, atopic) | IgE on mast cells | Seconds to minutes |
| II | Cytotoxic (antibody-mediated) | IgG or IgM against a cell-surface or matrix antigen | Minutes to hours |
| III | Immune complex | Antigen-antibody complexes deposited in tissue | 3 to 10 hours (up to weeks in serum sickness) |
| IV | Delayed (cell-mediated) | T lymphocytes and macrophages — NO antibody | 24 to 72 hours |
- Types I, II and III are antibody-mediated and can therefore be transferred by serum; type IV is cell-mediated and can be transferred only by cells. This is the single most useful way to hold the classification
- A type V (stimulatory) is sometimes added for antibodies that stimulate rather than destroy — the TSH-receptor antibody of graves disease
Type I — Immediate Hypersensitivity
First exposure — antigen drives a Th2 response with IL-4 → B cells class-switch to produce IgE → IgE binds high-affinity FcepsilonRI receptors on mast cells and basophils — the person is now sensitised but has no symptoms → second exposure — antigen cross-links adjacent IgE molecules → degranulation within seconds → preformed mediators — histamine, tryptase, heparin, chemotactic factors → newly synthesised mediators — leukotrienes (the old SRS-A), prostaglandins, platelet-activating factor, cytokines → early phase (minutes) — vasodilatation, increased permeability, bronchospasm, itch; then a late phase at 4–12 hours with eosinophil infiltration and sustained inflammation
- Examples — anaphylaxis, atopic asthma, allergic rhinitis, urticaria and angio-oedema, food and drug allergy, insect sting reactions
- Tests — skin prick test, intradermal test, serum specific IgE (RAST), and total IgE
- Treatment — adrenaline intramuscularly in anaphylaxis; antihistamines, corticosteroids and mast cell stabilisers for lesser reactions; allergen avoidance; and desensitisation (immunotherapy) in selected patients
CLINICAL PEARL
The first exposure causes no reaction, and that is what makes drug allergy so treacherous. Sensitisation is silent — the patient tolerates the drug perfectly, and the IgE is made afterwards. The reaction comes on a later exposure, often to a drug the patient and the doctor both know has been given safely before. A previous uneventful course is therefore no guarantee of safety.
Type II — Cytotoxic Hypersensitivity
- Mechanism — IgG or IgM binds an antigen on a cell surface or basement membrane, and damage follows by (1) complement activation and lysis, (2) opsonisation and phagocytosis, (3) antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells
- Examples — ABO-incompatible transfusion reaction; haemolytic disease OF the newborn (Rh incompatibility); autoimmune haemolytic anaemia and immune thrombocytopenia; goodpasture syndrome (anti-glomerular basement membrane antibody affecting kidney and lung); rheumatic carditis (molecular mimicry with streptococcal M protein); drug-induced cytopenias; and hyperacute graft rejection
- Antibodies that block or stimulate rather than destroy — myasthenia gravis (blocking the acetylcholine receptor) and graves disease (stimulating the TSH receptor)
- Test — the COOMBS (antiglobulin) test: direct detects antibody already on the patient’s red cells; indirect detects free antibody in the serum, and is used in cross-matching and antenatal screening
Type III and Type IV
| Feature | Type III — immune complex | Type IV — delayed |
|---|---|---|
| Mechanism | Soluble complexes formed in antigen excess are too small to be cleared and deposit in vessel walls, glomeruli, joints and skin; they fix complement, C5a attracts neutrophils, and enzyme release damages tissue | Sensitised CD4 Th1 cells recognise antigen and release cytokines (interferon-gamma) that recruit and activate macrophages; CD8 cells kill directly. Persistent antigen leads to granuloma formation |
| Timing | 3–10 hours; weeks in serum sickness | 24–72 hours (or weeks for granuloma) |
| Local example | ARTHUS reaction — local necrosis at a site of repeated antigen injection; hypersensitivity pneumonitis ("farmer’s lung") | Tuberculin (Mantoux) reaction; contact dermatitis to nickel, chromate and topical drugs |
| Systemic example | Serum sickness (fever, rash, arthralgia, proteinuria 7–10 days after heterologous serum); SLE; post-streptococcal glomerulonephritis; polyarteritis nodosa | Granulomatous disease — tuberculosis, leprosy, sarcoidosis, deep mycoses; graft rejection; and much of the tissue damage of these infections |
| Transferable by | Serum | Cells only |
| Histology | Neutrophils, fibrinoid necrosis, complement and immunoglobulin deposits | Lymphocytes and macrophages; epithelioid and giant cells |
Diagnostic Tests in Hypersensitivity
| Test | Type detected | Notes |
|---|---|---|
| Skin prick test | Type I | Read at 15–20 minutes as a wheal and flare; requires a positive (histamine) and negative control; antihistamines must be stopped beforehand. Resuscitation facilities must be available |
| Intradermal test | Type I | More sensitive but greater risk of a systemic reaction |
| Serum specific IgE (RAST) | Type I | Safe where skin testing is impossible — extensive eczema, dermographism, or inability to stop antihistamines |
| Serum tryptase | Type I | Rises after mast cell degranulation; confirms anaphylaxis retrospectively |
| COOMBS (antiglobulin) test | Type II | Direct detects antibody already coating the red cells; indirect detects free antibody in serum and is used for cross-matching and antenatal screening |
| Complement levels, immune complexes, biopsy | Type III | Low C3 and C4 with immunofluorescence showing immunoglobulin and complement deposits |
| Patch test | Type IV | Applied to the back and read at 48 and 96 hours; identifies contact allergens |
| Mantoux (tuberculin) test | Type IV | 0.1 mL of PPD intradermally, read at 48–72 hours as the diameter of induration (not erythema) |
Applied Aspects
- In tuberculosis and leprosy, much of the tissue damage is type IV hypersensitivity rather than the organism itself — which is why corticosteroids are given in tuberculous meningitis and pericarditis, and in type 1 lepra reactions to save nerve function
- The Mantoux test measures exposure, not disease, and in a country with universal BCG and high background infection its positive predictive value is limited; a negative test does not exclude tuberculosis, particularly in miliary disease, HIV or malnutrition, where anergy occurs
- Give anti-D immunoglobulin to Rh-negative mothers after delivery of an Rh-positive infant and after any sensitising event; it prevents haemolytic disease of the newborn by removing fetal cells before the mother can respond
- Ask about previous reactions before giving heterologous serum — antivenom, antitoxin — and have adrenaline drawn up; but never withhold antivenom from an envenomated patient for fear of a reaction, since the alternative is death
- Adrenaline is the only drug that reverses every feature of anaphylaxis, and antihistamines and steroids must never delay it
- Contact dermatitis is a common occupational problem — nickel, chromate in cement, rubber accelerators, and topical antibiotics; patch testing identifies the agent and avoidance is the treatment
- Read the Mantoux as induration, not erythema, at 48 to 72 hours; measuring redness is a common and consequential error
- Desensitisation (allergen immunotherapy) works by shifting the response from IgE toward IgG blocking antibody and regulatory T cells; it is effective for venom and pollen allergy but must be done where anaphylaxis can be treated
- Type II and type III are distinguished by where the antigen is — fixed on a cell surface in type II, soluble and forming circulating complexes in type III; the mediators overlap but the pattern of damage differs entirely
- Serum sickness is now seen chiefly with antivenom, antitoxin and some monoclonal antibodies, appearing 7 to 10 days after administration with fever, rash, arthralgia and proteinuria
- Atopy runs in families and tends to march — infantile eczema, then food allergy, allergic rhinitis and asthma; recognising the pattern allows earlier and better management
- Hypersensitivity pneumonitis is occupational and preventable — farmer’s lung, bagassosis, bird fancier’s lung; identifying and removing the exposure prevents irreversible fibrosis
- Type IV reactions to drugs may be severe — Stevens-Johnson syndrome and toxic epidermal necrolysis, associated with particular HLA types and with carbamazepine, allopurinol, sulphonamides and nevirapine
- Transfusion reactions span several types — acute haemolytic (type II, from ABO incompatibility and usually a clerical error), febrile non-haemolytic, allergic and anaphylactic (type I, notably in IgA deficiency)
- Check the identity of patient and unit at the bedside; ABO-incompatible transfusion is a preventable type II reaction and the fault is almost always administrative rather than immunological
- Latex allergy is an occupational hazard for healthcare workers, and cross-reacts with banana, avocado and kiwi; powder-free and synthetic gloves have greatly reduced it
- Anaphylaxis to antivenom must never prevent its use in an envenomated patient; adrenaline is drawn up first, the reaction treated, and the antivenom continued
All questions in Immunology
- Q1Classify immunity. Describe the organs and cells of the immune system and the mechanisms of innate immunity. ★
- Q2Define antigen and hapten. Describe the structure and classes of immunoglobulins and the primary and secondary immune response. ★
- Q3Describe the complement system with its pathways, functions and the effects of its deficiencies. ★
- Q4Classify hypersensitivity reactions. Describe each type with its mechanism and examples. ★
- Q5Describe antigen processing and presentation, and the humoral and cell-mediated immune responses. Add a note on tolerance. ★
- SN1Describe the structure and classes of immunoglobulins with their functions. ★
- SN2Describe the antigen-antibody reactions used in the laboratory and the interpretation of serological results. ★
- SN3Describe the principle, types and applications of ELISA. ★
- SN4Describe anaphylaxis with its mechanism, clinical features and management. ★
- SN5Describe the MHC (HLA) system and transplantation immunology including graft rejection. ★
- SN6Define autoimmunity. Describe its mechanisms, classification and the autoantibodies of diagnostic value. ★
- SN7Classify immunodeficiency disorders. Describe their features, investigation and management.